How does Napavir sodium/Salanca help prevent AIDS?

Although the initial research and development focus of Sunlenca (Sunlenca) is to provide new treatments for multi-drug-resistant HIV-infected patients, its unique pharmacological characteristics also allow it to show great potential in the field of AIDS prevention. Compared with traditional PrEP (pre-exposure prophylaxis) drugs that need to be taken daily, Sunlenca's six-month-long long-lasting injection model is expected to significantly improve prevention compliance and provide a new option for people who have difficulty persisting in taking daily medication.

In terms of mechanism of action, lenapavir sodium blocks multiple key steps in the virus life cycle, including virus entry into the nucleus, integration, assembly and release, by interfering with the function of the HIV capsid protein. This means that it can block the virus at the early stage of invading the host, thereby effectively reducing the risk of infection. Theoretically, this multi-link intervention model can make the preventive effect more lasting and stable.

At the international research level, there are currently a number of clinical trials exploring the feasibility of Sunlenca in HIV prevention. For example, some ongoing studies are trying to validate its effectiveness as long-acting PrEP, which, if successful, could become the first biannual HIV prevention regimen. This has important public health value for high-risk groups, those with poor compliance, even in resource-limited settings.

However, it should be pointed out that as of now, the indications of lenapavir sodium are still limited to the treatment of drug-resistant HIV-infected patients, and it has not yet received formal approval from any regulatory agency for preventive use. Therefore, its application in HIV prevention is still in the clinical exploration stage and is still far away from large-scale promotion. For the general population, it is still recommended to use approved oral PrEP drugs, such as tenofovir/emtricitabine fixed combination preparations. These drugs have been proven to be safe and effective and are widely used in daily prevention among high-risk groups.

Reference materials:https://www.drugs.com/sunlenca.html